S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
S&P 500   4,970.64 (-0.81%)
DOW   37,853.71 (+0.21%)
QQQ   415.91 (-1.77%)
AAPL   164.25 (-1.67%)
MSFT   398.79 (-1.36%)
META   482.93 (-3.76%)
GOOGL   153.41 (-1.67%)
AMZN   174.62 (-2.57%)
TSLA   148.76 (-0.78%)
NVDA   805.31 (-4.89%)
AMD   147.96 (-4.59%)
NIO   3.81 (-4.75%)
BABA   68.52 (-0.52%)
T   16.34 (+0.06%)
F   12.09 (+0.25%)
MU   106.97 (-4.43%)
GE   148.61 (-2.83%)
CGC   8.01 (+2.30%)
DIS   111.29 (-1.01%)
AMC   3.18 (+8.90%)
PFE   25.80 (+1.61%)
PYPL   61.77 (-0.53%)
XOM   119.89 (+1.16%)
Free Trial
CVE:HIV

HIVE Blockchain Technologies (HIV) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)
Free HIV Stock Alerts
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

HIV Stock News Headlines

April 17, 2024 | msn.com
IIT K & 'Blockchain for Impact' forge strategic partnership to accelerate healthcare innovation in India
April 14, 2024 | msn.com
Rising Tensions in the U.S.-China AI Arms Race
April 19, 2024 | DTI (Ad)
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
April 4, 2024 | msn.com
Celebrate nature at The HIVE’s 3rd annual Nature Day event
March 29, 2024 | techrepublic.com
Course Deal: Master the Essentials of Blockchain and Crypto for $19.97
March 11, 2024 | msn.com
Biggest stock movers today: Crypto-linked stocks, MESO and more
March 2, 2024 | ca.finance.yahoo.com
HIVE Apr 2024 1.000 call
February 9, 2024 | msn.com
Cryptocurrency-linked stocks surge in pre-market trading as Bitcoin hits the $46,000 milestone
April 19, 2024 | DTI (Ad)
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
February 8, 2024 | msn.com
Ransomware payments hit an unfortunate milestone in 2023 — over $1.1billion paid out as hackers rake in rewards
February 5, 2024 | tmcnet.com
Blockchain Technology Opportunities and Challenges for online casinos in 2024
February 5, 2024 | msn.com
The ransomware business is booming, even as enforcers shut down some major players
February 3, 2024 | msn.com
A tsunami of AI-driven attacks expected in 2024
See More Headlines
Receive HIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HIVE Blockchain Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
4/19/2024
Next Earnings (Estimated)
7/04/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
CVE:HIV
CUSIP
N/A
CIK
N/A
Web
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

HIV Stock Analysis - Frequently Asked Questions

Should I buy or sell HIVE Blockchain Technologies stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HIVE Blockchain Technologies in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HIV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HIV, but not buy additional shares or sell existing shares.
View HIV analyst ratings or view top-rated stocks.

When is HIVE Blockchain Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our HIV earnings forecast.

How were HIVE Blockchain Technologies' earnings last quarter?

HIVE Blockchain Technologies Ltd. (CVE:HIV) issued its earnings results on Monday, February, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.16) by $0.05. The company had revenue of $42.55 million for the quarter, compared to analysts' expectations of $32.35 million.

How do I buy shares of HIVE Blockchain Technologies?

Shares of HIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HIV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
My biggest AI fear
Paradigm Press
Options trading has suddenly become more reliable.
Eagle Publishing